Pipeline
Pipeline
Transforming the landscape of global oncology with robust portfolio and first-in-class pipeline
Product | Target | Indication |
Clinical Site |
Pre | Phase 1 | Phase 2 | Phase 3 |
---|---|---|---|---|---|---|---|
Vactosertib |
TGF-β1 -signaling |
Osteosarcoma (monotherapy) |
US KOR |
|
|||
mCRC, NSCLC, r/rMM, Desmoid etc. (Combination strategy) |
US KOR |
|
|||||
MP010 | TME | Solid Tumors | - |
|
|||
MP2021 | TM4SF19 |
Osteoporosis, Arthritis, Bone metastatic disease |
- |
|
Category | Product | Target | Indication | Clinical Sites | Preclinical | Phase 1 | Phase 2 | Phase 3 |
---|---|---|---|---|---|---|---|---|
Oncology | Vactosertib |
TGF-β1 -signaling |
Osteosarcoma (monotherapy) |
US KOR |
US FDA ODD, RPDD, FTD and EU OMPD
|
|||
mCRC, NSCLC, r/rMM, Desmoid etc. (Combination strategy) |
US KOR |
Exploring indication expansion
|
||||||
MP010 | TME | Solid Tumors | - |
|
||||
Healthy Aging |
MP2021 | TM4SF19 |
Osteoporosis, Arthritis, Bone metastatic disease |
- |
|